Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy. Read more about Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy.
A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence. Read more about A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence.
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas. Read more about cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.
Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations. Read more about Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations.
EGFR and EGFRvIII coopt host defense pathways promoting progression in glioblastoma. Read more about EGFR and EGFRvIII coopt host defense pathways promoting progression in glioblastoma.
Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the PBTA and PNOC. Read more about Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the PBTA and PNOC.
Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasis. Read more about Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasis.
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions. Read more about Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions.
Investment in the team approach to enhance the Journal's impact. Read more about Investment in the team approach to enhance the Journal's impact.
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. Read more about Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.
